Story · Medicine & Biotech

Aakash Desai: “Playing Chess With Cancer” in EGFRm NSCLC

1 outlet · first reported by OncoDaily on

Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “My 2022 JAMA Oncology essay ‘Avoiding Checkmate’, seems relevant for thinking about EGFR lung cancer. Post-osimertinib EGFRm NSCLC: (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study peer-reviewed
    Aakash Desai: “Playing Chess With Cancer” in EGFRm NSCLC

    Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “My 2022 JAMA Oncology essay ‘Avoiding Checkmate’, seems relevant for thinking about EGFR lung cancer. Post-osimertinib EGFRm NSCLC:

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.